Dynapres 0.4 mg Capsule
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Dynapres 0.4 mg Capsule contains tamsulosin, an alpha-adrenergic antagonist. Its labelling describes it for the treatment of benign prostatic hyperplasia, a non-cancerous condition of an enlarged prostate gland in men. It is described as improving symptoms such as problems passing urine, making it easier to urinate, without changing the size of the prostate gland. The medicine may take approximately 6 months to show results, so consistent use is required.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of benign prostatic hyperplasia
- Described as controlling symptoms such as problems passing urine
- Described as not changing the size of the prostate gland
Described Dosage & Administration
- An oral medicine taken at the same time daily, as directed by the doctor
- The capsule should not be crushed or chewed; the medicine should not be stopped without informing the doctor, as this can worsen symptoms
- The full course of treatment should be completed; results may take approximately 6 months, so consistency is required
Described Side Effects
Described side effects include:
- Dizziness
- Chest pain
- Ejaculation disorder
The doctor should be informed immediately if side effects last long.
Precautions
- Healthy lifestyle changes are advised — urinating when the urge is felt and not straining the bladder
- Alcohol and caffeinated drinks should be avoided at night, especially before sleep
- The doctor should be informed of liver disease (frequent follow-ups on liver health may be required) and of any other medicines being taken
- Expectant or breastfeeding women should consult their doctor before treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains tamsulosin and is used for the treatment of benign prostatic hyperplasia. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as an oral capsule taken at the same time daily as directed by the doctor, not crushed or chewed, and not stopped without informing the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.